Clinical features and outcomes of disseminated infections caused by non-tuberculous mycobacteria in a university hospital in Taiwan, 20042008

Scandinavian Journal of Infectious Diseases

Volumn 43, Issue 1, 2010, Pages 8-14

  Chou, Chien Hong ^a   Chen, Hsin Yi ^a   Chen, Chung Yu ^a   Huang, Chun Ta ^a   Lai, Chih Cheng ^b   Hsueh, Po Ren ^a  

^a NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

^b CHI MEI MEDICAL CENTER   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; BACTERIUM ISOLATION; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; FEMALE; FEVER; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MALE; MIXED INFECTION; MORTALITY; MYCOBACTERIOSIS; MYCOBACTERIUM; MYCOBACTERIUM AVIUM; PROGNOSIS; TAIWAN; TREATMENT OUTCOME; UNIVERSITY HOSPITAL;

ADULT; ANTI-BACTERIAL AGENTS; BLOOD; COMORBIDITY; FEMALE; HIV INFECTIONS; HOSPITALS, UNIVERSITY; HUMANS; MALE; MIDDLE AGED; MYCOBACTERIUM AVIUM COMPLEX; MYCOBACTERIUM INFECTIONS, ATYPICAL; RESPIRATORY SYSTEM; RETROSPECTIVE STUDIES; RISK FACTORS; TAIWAN; TREATMENT OUTCOME;

EID: 78650298949     PISSN: 00365548     EISSN: 16511980     Source Type: Journal    
DOI: 10.3109/00365548.2010.519345     Document Type: Article

References (33)

1. Falkinham JO. Surrounded by mycobacteria: nontuberculous mycobacteria in the human environment. J Appl Microbiol 2009;107:356-67.
2. Lai CC, Tan CK, Chou CH, Hsu HL, Liao CH, Huang YT, et al. Increasing incidence of nontuberculous mycobacteria, Taiwan, 2000-2008. Emerg Infect Dis 2010;16:294-6.
3. Wayne LG. The impact of new technology on the laboratory s contribution to the diagnosis and management of mycobacterial disease. Kekkaku 1993;68:113-29.
4. Griffith DE, Aksamit T, Brown-Elliott BA, Catanzaro A, Daley C, Gordin F, et al.; ATS Mycobacterial Diseases Subcommittee; American Thoracic Society; Infectious Disease Society of America An official ATS/IDSA statement: Diagnosis, treatment, and prevention of nontuberculous mycobacterial diseases. Am J Respir Crit Care Med 2007; 175: 367-416.
5. Chin DP, Hopewell PC. Mycobacterial complications of HIV infection. Clin Chest Med 1996;17:697-711.
6. Horsburgh CR Jr. Epidemiology of disease caused by nontuberculous mycobacteria. Semin Respir Infect 1996;11:244-51.
7. Nicholson O, Feja K, LaRussa P, George D, Unal E, Della Latta P, et al. Nontuberculous mycobacterial infections in pediatric hematopoietic stem cell transplant recipients: case report and review of the literature. Pediatr Infect Dis J 2006;25:263-7. (Pubitemid 43379071)
8. Horsburgh CR Jr, Selik RM. The epidemiology of disseminated nontuberculous mycobacterial infection in the acquired immunodefi ciency syndrome (AIDS). Am Rev Respir Dis 1989;139:4-7.
9. Wei MC, Banaei N, Yakrus MA, Stoll T, Gutierrez KM, Agarwal R. Nontuberculous mycobacteria infections in immunocompromised patients: single institution experience. J Pediatr Hematol Oncol 2009;31:556-60.
10. Lai CC, Lee LN, Ding LW, Yu CJ, Hsueh PR, Yang PC. Emergence of disseminated infections due to nontuberculous mycobacteria in non-HIV-infected patients, including immunocompetent and immunocompromised patients in a university hospital in Taiwan. J Infect 2006;53:77-84.
11. Liao CH, Chen MY, Hsieh SM, Sheng WH, Hung CC, Chang SC. Discontinuation of secondary prophylaxis in AIDS patients with disseminated non-tuberculous mycobacteria infection. J Microbiol Immunol Infect 2004;37:50-6.
12. Chetchotisakd P, Kiertiburanakul S, Mootsikapun P, Assanasen S, Chaiwarith R, Anunnatsiri S. Disseminated nontuberculous mycobacterial infection in patients who are not infected with HIV in Thailand. Clin Infect Dis 2007;45:421-7.
13. Pfyffer GE. Mycobacterium: general characteristics, laboratory detection, and staining procedures. In: Murray PR, Baron EJ, Jorgensen JH, Landry ML, Pfaller MA, editors. Manual of clinical microbiology. 9 th ed. Vol. 1. Washington, DC: American Society for Microbiology; 2007.
14. Turenne CY, Tschetter L, Wolfe J, Kabani A. Necessity of quality-controlled 16S rRNA gene sequence databases: identifying nontuberculous Mycobacterium species. J Clin Microbiol 2001;39:3637-48.
15. Relman DA, Loutit JS, Schmidt TM, Falkow S, Tompkins LS. The agent of bacillary angiomatosis. An approach to the identifi cation of uncultured pathogens. N Engl J Med 1990;323:1573-80.
16. Corti M, Palmero D. Mycobacterium avium complex infection in HIV/AIDS patients. Expert Rev Anti Infect Ther 2008;6:351-63.
17. Nightingale SD. Prophylaxis against Mycobacterium aviumintracellulare complex infections in human immunodefi-ciency virus-infected patients. Infection 1997;25:67-70.
18. Tumbarello M, Tacconelli E, de Donati KG, Bertagnolio S, Longo B, Ardito F, et al. Changes in incidence and risk factors of Mycobacterium avium complex infections in patients with AIDS in the era of new antiretroviral therapies. Eur J Clin Microbiol Infect Dis 2001;20:498-501.
19. Nightingale SD, Byrd LT, Southern PM, Jockusch JD, Cal SX, Wynne BA. Incidence of Mycobacterium avium-intracellulare complex bacteremia in human immunodefi ciency virus-positive patients. J Infect Dis 1992;165:1082-5.
20. Horsburgh CR Jr, Gettings J, Alexander LN, Lennox JL. Disseminated Mycobacterium avium complex disease among patients infected with human immunodefi ciency virus, 1985-2000. Clin Infect Dis 2001;33:1938-43.
21. Gordin FM, Cohn DL, Sullam PM, Schoenfelder JR, Wynne BA, Horsburgh CR Jr. Early manifestations of disseminated Mycobacterium avium complex disease: a prospective evaluation. J Infect Dis 1997;176:126-32.
22. Abellán-Martínez J, Guerra-Vales JM, Ferná n dez-Cotarelo MJ, Gonz á lez-Alegre MT, Evolution of the incidence and aetiology of fever of unknown origin (FUO), and survival in HIV-infected patients after HAART (highly active antiretroviral therapy). Eur J Intern Med 2009; 20: 474-477.
23. Ristola MA, von Reyn CF, Arbeit RD, Soini H, Lumio J, Ranki A, et al. High rates of disseminated infection due to nontuberculous mycobacteria among AIDS patients in Finland. J Infect 1999;39:61-7.
24. Ingram CW, Tanner DC, Durack DT, Kernodle GW Jr, Corey GR. Disseminated infection with rapidly growing mycobacteria. Clin Infect Dis 1993;16:463-71.
25. H sieh SM, Hung CC, Chen MY, Hsueh PR, Chang SC, Luh KT. The role of tissue studies in facilitating early initiation of antimycobacterial treatment in AIDS patients with disseminated mycobacterial disease. Int J Tuberc Lung Dis 1999;3:521-7.
26. Ker CC, Hung CC, Huang SY, Chen MY, Hsieh SM, Lin CC, et al. Comparison of bone marrow studies with blood culture for etiological diagnosis of disseminated mycobacterial and fungal infection in patients with acquired immunodefi ciency syndrome. J Microbiol Immunol Infect 2002;35:89-93.
27. Hsieh SM, Hung CC, Chen MY, Hsueh PR, Chang SC, Luh KT. Clinical features and outcome in disseminated mycobacterial diseases in AIDS patients in Taiwan. AIDS 1998; 12:1301-7.
28. Kalayjian RC, Toossi Z, Tomashefski JF Jr, Carey JT, Ross JA, Tomford JW, Blinkhorn RJ Jr. Pulmonary disease due to infection by Mycobacterium avium complex in patients with AIDS. Clin Infect Dis 1995;20:1186-94.
29. Diagnosis and treatment of disease caused by nontuberculous mycobacteria. This offi cial statement of the American Thoracic Society was approved by the Board of Directors, March 1997. Medical Section of the American Lung Association. Am J Respir Crit Care Med 1997; 156:S1-25.
30. Döffi nger R, Dupuis S, Picard C, Fieschi C, Feinberg J, Barcenas-Morales G, Casanova JL. Inherited disorders of IL-12- and IFNgamma-mediated immunity: a molecular genetics update. Mol Immunol 2002;38:903-9.
31. Patel SY, Doffi nger R, Barcenas-Morales G, Kumararatne DS. Genetically determined susceptibility to mycobacterial infection. J Clin Pathol 2008;61:1006-12.
32. Höflich C, Sabat R, Rosseau S, Temmesfeld B, Slevogt H, Döcke WD, et al. Naturally occurring anti-IFN-gamma autoantibody and severe infections with Mycobacterium chelonae and Burkholderia cocovenenans. Blood 2004; 103: 673-5.
33. Patel SY, Ding L, Brown MR, Lantz L, Gay T, Cohen S, et al. Anti-IFN-gamma autoantibodies in disseminated nontuberculous mycobacterial infections. J Immunol 2005; 175:4769-76.